4.0
17. Nov. 2015
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Pay well and good opportunity for growth
Kontras
Like many global pharmaceutical companies they had changing priorities and challenges with mergers